Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
⚠️ Key Point: Calcium channel blocker (CCB) toxicity is a medical emergency with potentially fatal cardiovascular collapse. Immediate recognition and high-level supportive care are crucial.
💡 Teaching tip: Treatment aims to support perfusion, restore calcium availability, and enhance myocardial metabolism.
| Therapeutic Step | Intervention | Rationale / Notes |
|---|---|---|
| 1️⃣ Resuscitation & Monitoring | Admit to CCU/ICU; establish IV access, cardiac monitoring, frequent BP and glucose checks. | Prevents sudden deterioration and guides titration of therapies. |
| 2️⃣ Circulatory Support | IV crystalloids ± vasopressors (noradrenaline, dopamine if refractory). | Restores preload and counters vasodilatory shock. |
| 3️⃣ Bradycardia | IV Atropine 0.6–1.2 mg repeated as needed (max 3 mg).
Temporary pacing if refractory. |
Enhances vagal suppression of SA/AV node depression. |
| 4️⃣ Calcium Therapy | 10–20 mL of 10% Calcium Gluconate IV over 5–10 min; repeat as needed or give continuous infusion (0.5–1.5 mL/kg/hr). | Increases extracellular Ca²⁺, partially overcoming channel blockade and improving inotropy. |
| 5️⃣ Hyperinsulinaemic Euglycaemic (HIE) Therapy | High-dose insulin infusion (starting 1 U/kg bolus → 0.5–1 U/kg/hr) + IV dextrose; monitor glucose and K⁺. | Insulin enhances myocardial carbohydrate utilisation and contractility; key evidence-based therapy. |
| 6️⃣ Glucagon | 3–10 mg IV bolus followed by infusion (3–5 mg/hr) if persistent hypotension or bradycardia. | Stimulates cAMP independent of β-receptors, increasing inotropy and chronotropy. |
| 7️⃣ Lipid Emulsion Therapy | 20% Intralipid: 1.5 mL/kg bolus, then 0.25–0.5 mL/kg/min infusion (max 10 mL/kg over 30 min). | “Lipid sink” binds lipophilic drugs like verapamil or amlodipine; used for refractory cases. |
| 8️⃣ Decontamination | Activated charcoal (if within 1 h of ingestion); whole-bowel irrigation for sustained-release preparations. | Reduces further absorption of drug. |
| 9️⃣ Advanced Support | Temporary transvenous pacing, ECMO (Extracorporeal Membrane Oxygenation) if refractory shock. | Bridges to recovery when pharmacological measures fail. |
In summary, calcium channel blocker overdose causes profound cardiovascular collapse due to depressed calcium-dependent contractility and conduction. The cornerstone of management is early, aggressive supportive therapy — particularly HIE infusion and calcium supplementation — delivered in an intensive care setting.